ONCOtherapeutics Competitors and Similar CompaniesClear all

CEL-SCI's competitors and similar companies include Abliva and Elixiron Immunotherapeutics.

	CEL-SCI CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.	Abliva Abliva is a biotech company that discovers and develops medicines for the treatment of mitochondrial disease.	Elixiron Immunotherapeutics Elixiron Immunotherapeutics is a biotechnology company that develops therapies for immunological and degenerative diseases.
Founding Date	Founding Date 1983	Founding Date 2000	Founding Date 2017
Type	Type Public	Type Subsidiary	Type Private
Tags	Tags Healthcare biotech clinical research drug development therapy	Tags Healthcare biotech clinical research drug development pharma	Tags Healthcare biotech clinical research drug development therapy
Locations	Locations Vienna, US HQ	Locations Lund, SE HQ	Locations TW HQ
Employees	Employees N/A	Employees 950% increase	Employees 19
Financial
Net income	Net income ($25.4m) (FY, 2025)	Net income (kr90m) (FY, 2024)	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 10.8m	Total funding raised $ 37.5m

For sources of this data, please see the company profile

Lund, SE

Abliva is a biotech company that discovers and develops medicines for the treatment of mitochondrial disease.

Employees

Elixiron Immunotherapeutics is a biotechnology company that develops therapies for immunological and degenerative diseases.

Financial